SCHEMBL8264120

SCHEMBL8264120

Cc1cccc(-c2ccc3cn[nH]c3c2)c1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 11/20 0.70
FGFR2 P21802 5/20 0.61
FGFR3 P22607 2/20 0.61
KDM4E B2RXH2 2/20 0.55
HTT P42858 2/20 0.55
ALDH1A1 P00352 1/20 0.55
TGFBR1 P36897 1/20 0.53
TGFBR2 P37173 1/20 0.53
DYRK1A Q13627 4/20 0.51
CLK2 P49760 3/20 0.51
CLK4 Q9HAZ1 3/20 0.51
DYRK3 O43781 2/20 0.51
GSK3B P49841 2/20 0.51
CDK5 Q00535 2/20 0.51
CLK1 P49759 1/20 0.51
CLK3 P49761 1/20 0.51
CDK5R1 Q15078 1/20 0.51
DYRK2 Q92630 1/20 0.51
DYRK1B Q9Y463 1/20 0.51
PIK3CD O00329 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13680578 0.87 GSK3B (0.70) FGFR1TGFBR1DYRK1ACLK2CLK4
SCHEMBL13115655 0.84 FGFR1 (0.71) FGFR1FGFR2FGFR3KDM4EHTT
SCHEMBL18042017 0.83 TGFBR1 (0.69) FGFR1FGFR2FGFR3KDM4EHTT
SCHEMBL18041596 0.83 FGFR1 (0.49) FGFR1FGFR2FGFR3KDM4EHTT
SCHEMBL15640161 0.83 FGFR1 (0.51) FGFR1FGFR2FGFR3KDM4EHTT
SCHEMBL29677124 0.83 FGFR1 (0.49) FGFR1FGFR2FGFR3KDM4EHTT
SCHEMBL2460902 0.82 FGFR1 (1.00) FGFR1FGFR2FGFR3KDM4EHTT
SCHEMBL18041898 0.82 FGFR1 (0.48) FGFR1FGFR2FGFR3KDM4EHTT
SCHEMBL18041819 0.81 TGFBR1 (0.70) FGFR1FGFR2FGFR3KDM4EHTT
SCHEMBL29677020 0.81 TGFBR1 (0.70) FGFR1FGFR2FGFR3KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1833816-B1 SUBSTITUTED PIPERIDINES AS RENIN INHIBITORS NOVARTIS AG (CH) 2009-11-11 EP disclosed
WO-2006069788-A1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2006-07-06 WO disclosed